Michael Mix
Michael Mix
Akademischer Direktor, University of Freiburg, Germany
Adresse e-mail validée de mix-medical.de
Citée par
Citée par
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET
MJ Reinhardt, C Ehritt-Braun, D Vogelgesang, C Ihling, S Högerle, ...
Radiology 218 (3), 776-782, 2001
Impact of [18 F] FDG-PET on the primary staging of small-cell lung cancer
I Brink, T Schumacher, M Mix, S Ruhland, E Stoelben, W Digel, M Henke, ...
European journal of nuclear medicine and molecular imaging 31 (12), 1614-1620, 2004
Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events
TH Schindler, EU Nitzsche, HR Schelbert, M Olschewski, J Sayre, M Mix, ...
Journal of the American College of Cardiology 45 (9), 1505-1512, 2005
FDG-PET imaging for the staging and follow-up of small cell lung cancer
T Schumacher, I Brink, M Mix, M Reinhardt, G Herget, W Digel, M Henke, ...
European journal of nuclear medicine 28 (4), 483-488, 2001
Impact of 18 F-FDG-positron emission tomography for decision making in colorectal cancer recurrences
A Imdahl, MJ Reinhardt, EU Nitzsche, M Mix, A Dingeldey, A Einert, ...
Langenbeck's archives of surgery 385 (2), 129-134, 2000
Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison …
C Zamboglou, V Drendel, CA Jilg, HC Rischke, TI Beck, ...
Theranostics 7 (1), 228, 2017
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short-and long-term vitamin C …
TH Schindler, EU Nitzsche, T Munzel, M Olschewski, I Brink, M Jeserich, ...
Journal of the American College of Cardiology 42 (5), 814-822, 2003
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy
T Shepherd, M Teras, RR Beichel, R Boellaard, M Bruynooghe, V Dicken, ...
IEEE transactions on medical imaging 31 (11), 2006-2024, 2012
Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors
TH Schindler, EU Nitzsche, M Olschewski, N Magosaki, M Mix, JO Prior, ...
Circulation 110 (9), 1069-1075, 2004
PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography
TH Schindler, EU Nitzsche, M Olschewski, I Brink, M Mix, J Prior, A Facta, ...
Journal of Nuclear Medicine 45 (3), 419-428, 2004
68Ga-HBED-CC-PSMA PET/CT versus histopathology in primary localized prostate cancer: a voxel-wise comparison
C Zamboglou, F Schiller, T Fechter, G Wieser, CA Jilg, A Chirindel, ...
Theranostics 6 (10), 1619, 2016
Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy
MI Bittner, N Wiedenmann, S Bucher, M Hentschel, M Mix, WA Weber, ...
Radiotherapy and Oncology 108 (3), 511-516, 2013
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma
I Brink, M Hentschel, TA Bley, A Walch, M Mix, M Kleimaier, E Moser, ...
European Journal of Surgical Oncology (EJSO) 30 (5), 544-550, 2004
Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome
NE Wiedenmann, S Bucher, M Hentschel, M Mix, W Vach, MI Bittner, ...
Radiotherapy and oncology 117 (1), 113-117, 2015
Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?
EU Nitzsche, S Hoegerle, M Mix, I Brink, A Otte, E Moser, A Imdahl
European journal of nuclear medicine and molecular imaging 29 (2), 237-242, 2002
Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent …
TH Schindler, E Nitzsche, N Magosaki, I Brink, M Mix, M Olschewski, ...
Heart 89 (5), 517-526, 2003
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ...
The Lancet Oncology 21 (4), 581-592, 2020
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate-and high-risk prostate cancer-a …
C Zamboglou, M Carles, T Fechter, S Kiefer, K Reichel, TF Fassbender, ...
Theranostics 9 (9), 2595, 2019
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA)–protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
O Oehlke, M Mix, E Graf, T Schimek-Jasch, U Nestle, I Götz, ...
BMC cancer 16 (1), 1-10, 2016
Lymph node staging in extracranial head and neck cancer with FDG PET–appropriate uptake period and size-dependence of the results
I Brink, T Klenzner, T Krause, M Mix, UH Ross, E Moser, EU Nitzsche
Nuklearmedizin 41 (02), 108-113, 2002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20